最高3个月国际标准化比值(INR):超声引导下肝活检后出血的预测因素
回顾性分析870例连续接受非靶向超声引导经皮肝活检患者,活检后出血发生率2.0%(17/870),需干预者0.8%(7/870)。活检前3个月内最高INR预测出血优于最近一次INR(AUC=0.79 vs 0.61,p=0.003),INR>1.8预测准确性最高;总胆红素为独立预测因素(AUC=0.73),肌酐预测能力差(AUC=0.61)。作者认为最高INR应纳入患者风险分层。
要点
- 活检前3个月内最高INR预测出血优于最近一次INR(AUC 0.79 vs 0.61,p=0.003)。
- INR>1.8对出血的预测准确性最高,可辅助风险分层。
- 总胆红素为独立预测因素(AUC=0.73),肌酐预测能力差(AUC=0.61)。
核心结论
- 超声引导下经皮肝活检前3个月内最高INR与术后出血相关,且预测能力优于最近一次INR,应考虑用于患者风险分层。
研究设计与样本
- 单中心回顾性研究,纳入2016年1月至2019年12月连续870例(年龄53±14岁;53%(459/870)男性)接受非靶向超声引导经皮肝活检的患者,采用描述性统计和逻辑回归分析实验室值与活检后出血风险的关系,并构建ROC曲线和AUC评估预测能力。
诊断标准与关键数值
- 活检后出血发生率2.0%(17/870),需干预者0.8%(7/870);最高INR预测出血AUC=0.79,最近一次INR AUC=0.61(p=0.003);总胆红素AUC=0.73;肌酐AUC=0.61;最高INR与总胆红素联合AUC=0.80 vs 单用INR 0.79;使用最高INR的MELD评分AUC=0.79,使用最近一次INR的MELD评分AUC=0.74;INR>1.8预测准确性最高。
临床应用与阅片要点
- 作者认为最高INR应纳入活检前风险分层和临床决策,并考虑用于确定活检路径。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether international normalized ratio (INR), bilirubin, and creatinine predict bleeding risk following percutaneous liver biopsy.
METHODS: A total of 870 consecutive patients (age 53 ± 14 years; 53% (459/870) male) undergoing non-targeted, ultrasound-guided, percutaneous liver biopsy at a single tertiary center from 01/2016 to 12/2019 were retrospectively reviewed. Results were analyzed using descriptive statistics and logistic regression models to evaluate the relationship between individual and combined laboratory values, and post-biopsy bleeding risk. Receiver operating characteristic (ROC) curves and area under ROC (AUC) curves were constructed to evaluate predictive ability.
RESULTS: Post-biopsy bleeding occurred in 2.0% (17/870) of patients, with 0.8% (7/870) requiring intervention. The highest INR within 3 months preceding biopsy demonstrated the best predictive ability for post-biopsy bleeding and was superior to the most recent INR (AUC = 0.79 vs 0.61, p = 0.003). Total bilirubin is an independent predictor of bleeding (AUC = 0.73) and better than the most recent INR (0.61). Multivariate regression analysis of the highest INR and total bilirubin together yielded no improvement in predictive performance compared to INR alone (0.80 vs 0.79). The MELD score calculated using the highest INR (AUC = 0.79) and most recent INR (AUC = 0.74) were similar in their predictive performance. Creatinine is a poor predictor of bleeding (AUC = 0.61). Threshold analyses demonstrate an INR of > 1.8 to have the highest predictive accuracy for bleeding.
CONCLUSION: The highest INR in 3 months preceding ultrasound-guided percutaneous liver biopsy is associated with, and a better predictor for, post-procedural bleeding than the most recent INR and should be considered in patient risk stratification.
CLINICAL RELEVANCE STATEMENT: Despite correction of coagulopathic indices, the highest international normalized ratio within the 3 months preceding percutaneous liver biopsy is associated with, and a better predictor for, bleeding and should considered in clinical decision-making and determining biopsy approach.
KEY POINTS: • Bleeding occurred in 2% of patients following ultrasound-guided liver biopsy, and was non-trivial in 41% of those patients who needed additional intervention and had an associated 23% 30-day mortality rate. • The highest INR within 3 months preceding biopsy (AUC = 0.79) is a better predictor of bleeding than the most recent INR (AUC = 0.61). • The MELD score is associated with post-procedural bleeding, but with variable predictive performance largely driven by its individual laboratory components.
引用
- Vo NH, Sari MA, Grimaldi E, et al. Highest 3-month international normalized ratio (INR): a predictor of bleeding following ultrasound-guided liver biopsy. Eur Radiol. 2024. PMID: 38483589. doi:10.1007/s00330-024-10692-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。